Nicox’s Partner Ocumension Therapeutics Initiates ZERVIATE Phase 3 Clinical Trial in China
Press ReleaseNicox’s Partner Ocumension Therapeutics Initiates ZERVIATE Phase 3 Clinical Trial in China December 30, 2020 – release at 7:30...
News
Franciosi Consulting Assessing New Potential Treatments for Asthma and COPD
VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will...
iCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical Adoption
International Multi-Center Study to Commence January 2021 University of Louisville’s Trial on IORT for Large Brain Lesion Treatments Accelerating First...
LeMaitre Vascular to Present at Upcoming Investor Conferences
BURLINGTON, Mass., Dec. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor...
Osmotica Pharmaceuticals plc Receives Complete Response Letter from U.S. Food and Drug Administration for Arbaclofen Extended Release Tablets
BRIDGEWATER, N.J., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”) today announced that...
Predictive Oncology Announces Cancellation of Special Meeting in December 2020
Reincorporation Proposal Received Overwhelming Support Among Shares VotedNEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) (the...
Immutep Secures United States Patent For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitor
Sydney, AUSTRALIA, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology...
Lui Franciosi Reviewing the Use of Sugar-Based Molecules as Potential Treatments for COVID-19
VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will...
Eve & Co Announces Share Consolidation
TORONTO, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Eve & Co. Incorporated (TSXV: EVE) (OTCQX: EEVVF) (the “Company” or “Eve &...
VAXIL Provides Update on USAMRIID and Oral Experiments
NESS-ZIONA, Israel, Dec. 29, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of Existing Convertible Note on Improved Terms
Represents Draw of Additional Proceeds from Petrichor Announced in January 2020IRVINE, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro,...
Emergent BioSolutions and Mount Sinai Health System Announce Initiation of DOD-Funded Clinical Program to Evaluate COVID-19 Human Hyperimmune Globulin (COVID-HIG) Product Candidate for Prophylaxis
GAITHERSBURG, Md. and NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) and Mount Sinai Health System...
Assertio Announces Transfer of Listing from Nasdaq Global Select Market to Nasdaq Capital Market
Company Receives additional 180-day grace period, until June 28, 2021, to satisfy the $1.00 bid price requirement to maintain Nasdaq...
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
European Union orders 100 million additional doses of COMIRNATY® bringing total doses to 300 million for 27 EU member states...
Oyster Point Pharma to Participate in the 39th Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on...
Tauriga Sciences Inc. Completes Payment for the Entirety of its 3rd Production Run of its Gelatin Free, CBD Infused Gum Drop Product, Branded as: Tauri-Gummies
12_29 PR Snapshot of Tauri-Gummies™ EU Trademark The Company has Received Confirmation from its Contract Manufacturer, Concerning the Arrival of...
Satellite Healthcare Names Industry Veteran Jeffrey Goffman as CEO
SAN JOSE, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Satellite Healthcare, the leading nonprofit dialysis provider, today announced Jeffrey Goffman...
LifeLabs surpasses 1 million COVID-19 molecular tests completed
Toronto, Dec. 29, 2020 (GLOBE NEWSWIRE) -- LifeLabs is pleased to announce that it has completed over 1 million COVID-19...
UPDATE — BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021
NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused...
Transactions in connection with share buyback program
Company announcement no. 53 - 2029 December 2020 Transactions in connection with share buyback program On 18 November 2020 NTG...